CD248 and cancer: Among the potential biomarkers, TEM-1 appears as an emerging target, as it is expressed in tumor vessels and in the stroma of various cancers but has no or little expression in normal adult tissues (expression is limited to endometrial stroma and occasionally fibroblast) [33,34].